Bioelectronics Corp (BIEL)

[art2426]

Nah, this is just entirely entertaining to read all the praises for this leadership and company that has been in a downward spiral for years. Never deterring the pie in the sky posters, even as this stock price has justifiably plummeted to the bottom of where it has been trading for years. Now we get a post that says that this has beat last years sales by a measly $7000.00. THAT is GOOD? Last years were crap so equally that is better? Those sales did not make this company profitable. These sales need to increase exponentially to accomplish profitability. Something this company and leadership have been unable to accomplish in over 20 years in business.

Let's take a look at the low lights:
-Notes payable: $12,012,728. That is an increase of $150.973 from 2022 ($11.861,755). Looks like more loans occurring.
-Total stock to be issued from 2023 note conversions: 9,583,630,815 shares (that is billions). From 2022 conversions: 3,550,063,657 shares
-Total assets: $144,388. Total liabilities: $18,622,807. That is a 129:1 liability to asst ratio.
-Accumulated deficit: $39,814,199

Note the stock conversions that are coming from all those notes. Where are they going to get those shares as the authorized shares are just about maxed out? RED FLAG